medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 6

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2012; 50 (6)

Hospital outbreak of urinary tract infections by lubricant gel contaminated with

Ángeles-Garay U, Zacate-Palacios Y, López-Herrera JR, Hernández-Sánchez EA, Silva-Sánchez J, Ascencio-Montiel IJ
Full text How to cite this article

Language: Spanish
References: 17
Page: 615-622
PDF size: 98.01 Kb.


Key words:

Burkholderia cepacia, urinary tract infection, diseases outbreak.

ABSTRACT

Background: Burkholderia cepacia (B. cepacia) has been the causal agent of infectious hospital outbreaks.
Methods: a case-controls study was conducted to describe an outbreak of urinary tract infection associated to lubricant-gel contaminated with B. cepacia. Patients who developed UTIsc were included in this study. Their clinical data, urine cultures, antiobiograms and the molecular bacterial analysis were analyzed.
Results: the urine culture was positive in 101 (55.8 %); the bacterial strains isolated were: B. cepacia 30.7 %, Escherichia coli 22.7 %, Enterococcus faecalis 9.9 %, Enterococcus spp. 8.9 %. They were 31 patients with B. cepacia isolation that was taken as the cases group and 63 with UTIsc due to another organism as control group. The Charlson comorbidity index was 5.3 ± 1.8 for cases and 4.5 ± 1.2 for controls. The factors associated with death were: heart disease, diabetes, pneumonia, bacteremia and UTIsc B. cepacia.
Conclusions: the lubricant gel used for urinary catheter placement originated the outbreak. Heart disease, pneumonia, bacteremia and UTIsc B. cepacia were related to patients’ death.


REFERENCES

  1. Millar-Jones L, Paull A, Saunders Z, Goodchild MC. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet 1992;340(8817):491.

  2. Mahenthiralingam E, Urban TA, Goldberg JR. The multifarious, multireplicon Burkholderia cepacia complex. Nature Rev Microbiol 2005;3(2):144-156.

  3. Walsh MN, Casano AA, Manangan LP, Sinkowitz-Cochran RL, Jarvis WR. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis. J Pediatr 2002;141(4):512-517.

  4. Jacobson M, Wray R, Kovach D, Henry D, Speert D, Matlow A. Sustained endemicity of Burkholderia cepacia complex in a pediatric institution, associated with contaminated ultrasound gel. Infect Control Hosp Epidemiol 2006;27(4):362- 366. Disponible en http://www.jstor.org/stable/10.1086/ 503343

  5. Morel PC, Roubi N, Talon RD, Bertrand X. Contamination of trypan blue with Burkholderia cepacia in a cornea bank. Infect Control Hosp Epidemiol 2003;24(3):198-202.

  6. Estivaris CF, Bhatti LI, Pati R, Jensen B, Arduino MJ, Jeringan D, et al. An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray. Chest 2006; 130(5):1346-1353. Disponible en http://journal.publications. chestnet.org/article.aspx? articleid=1084784

  7. Stone S, Cooper BS, Kibbler C, Cookson B, Roberts J, Medley G, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrobiol Chemother 2007;59(5):833-840. Epub 2007 Mar 26. Review. Disponible en http://jac.oxfordjournals.org/content/59/5/ 833.long

  8. Hooton TM, Bradley SF, Cárdenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50(5):625-663. Disponible en http://cid.oxfordjournals. org/content/50/5/625.long

  9. Collins CH, Lyne P. Microbiological methods. Sixth edition. London: Butterworth; 1989.

  10. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33(9):2233-2239. Disponible en http://www.ncbi.nlm. nih.gov/pmc/articles/PMC228385/

  11. Kutty PK, Moody B, Guillion JS, Zervos M, Ajluni M, Washburn R, et al. Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash. Chest 2007; 132(6):1825-1831. Epub 2007 Oct 9. Disponible en http:// journal.publications.chestnet.org/article.aspx?articleid= 1085596

  12. Held MR, Begier EM, Beardsley DS, Broune FA, Martinello RA, Baltimore RS, et al. Life-threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state. Pediatrics 2006;118(1):e212-e215. Epub 2006 Jun 19. Disponible en http://pediatrics.aappublications.org/ content/118/1/e212.long

  13. Dizbay M, Tunccan OG, Sezer BE, Aktas F, Arman D. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance J Infect Dev Ctries 2009;3(4):273-277.

  14. Douce RW, Zurita J, Sánchez O, Cárdenas-Aldaz P. Investigation of an outbreak of central venous catheterassociated bloodstream infection due to contaminated water. Infect Control Hosp Epidemiol 2008;29(4):364-366.

  15. Mann T, Ben-David D, Zlotkin A, Shachar D, Keller N, Toren A, et al. An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients. Infection 2010;38(3):187-194.

  16. Heo ST, Kim SJ, Jeong YG, Bae IG, Jin JS, Lee JC. Hospital outbreak of Burkholderia stabilis bacteraemia related to contaminated chlorhexidine in haematological malignancy patients with indwelling catheters. J Hosp Infect 2008;70(3):241-245.

  17. OtaG F, Ersöz G, SalcioGlu M, Bal C, Schneider I, Bauernfeind A. Nosocomial bloodstream infections with Burkholderia stabilis. J Hosp Infect 2005;59(1):46-52.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2012;50